TRANSLATIONAL AND CLINICAL MEDICINE - Georgian Medical Journal

Background:  The choice of method of treatment of benign prostatic hyperplasia (BPH) in elderly patients with high operative risk is one of the pressing issues of modern urology. Selective arterial embolization (SAE) of the prostate – is a new method of treating lower urinary tract symptoms caused by benign prostatic hyperplasia.  

Materials and Method:  21 male patients with prostate volume larger than 40 ml, contraindications for traditional operations on the prostate, high level of operative-anesthesiological risk (III-IV on American Society of Anaesthesiologists scale) and normal PSA levels underwent SAE procedure under local anesthesia from one surgical approach through the right femoral artery. Patient`s levels of PSA total were monitored, a digital rectal examination was performed and an ultrasound investigation of the prostate was conducted, maximum urinary flow (Qmax) was measured, IPSS index and quality of life (QoL) subscore were determined.

Results and discussion: The intervention was performed successfully in 19 patients (90,5%). Subsequent examination revealed significant improvement of IPSS on average by 12 points and QoL levels on average by 3 points, reduction of the volume of the prostate at mean by 35%, and increase of maximal urine flow at mean by 32%. First signs of clinical improvement were observed one week after the intervention. No significant complications connected to angiography or embolization, which needed surgery or long-term hospitalization, were registered.

Conclusion: Our preliminary experience suggests that SAE is safe and effective for treatment of symptomatic BPH in elderly patients who have contraindications to traditional operations and high operative risk.  

Vozianov OF, Lulko OV. Urologija: Pidruchnyk dlja medinstytutiv [Urology: Textbook for medinstitutes]. Kyiv,Vyshha shkola.,2002.

Sajdakova NO, Starceva LM. Osnovni pokaznyky urologichnoi' dopomogy v Ukrai'ni za 2008–2009 rik (vidomche vydannja) [Basic indexes of urological help in Ukraine during 2008-2009 years (departmental edition)] Kyiv, 2009.

Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. The Journal of Urology. 1984 Sep;132(3):474-9.

Gidzyns'ka IM, Moroz GZ, Lasycja TS, Bezugla MV. Metabolichnyj syndrom ta sercevo-sudynnyj ryzyk: suchasnyj pogljad na problemu [Metabolic syndrome and cardiovascular risk: modern view on the problem] Kyiv. Arterial Hypertension. 2012; 2(22):111-7.

Ahyai SA1, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European Urology. 2010 Sep;58(3):384-97.

Leyh H, Necknig U. Transurethral prostatectomy: management of complications. Der Urologe Ausg. A. 2014 May;53(5):699-705.

Kurbatov DG, Dubskiĭ SA, Sitkin II, Lepetukhin AE. X-ray guided endovascular occlusion of prostate arteries-alternative innovative method of treatment for patients with large prostatic adenomas. Urologiia. 2013 Mar-Apr;(2):35-6, 38-40.

Carnevale FC, Antunes AA, da Motta Leal Filho JM. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovascular and interventional radiology. 2010; 33(2):355–61

Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Vaz Santos V, Oliveira AG. Prostatic arterial embolization for benign prostatic hyperplasia: short-and intermediate-term results. Radiology. 2013 Feb;266(2):668-77.

DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. Journal of Vascular and Interventional Radiology. 2000 Jun 30;11(6):767-70.